Genmab — September 2023
-
Sydbank-analytiker: Genmabs godkendelse i Japan og EU var ventet - men dog positivthttps://www.proinvestor.com/investornyt/1054016/sydbank-analytiker-genmabs-godkendelse-i-japan-og-eu-var-ventet-men-dog-positivt
-
LUAF82422 ser ud til at forsætte (genstarte) med en såkaldt "optional open-label treatment extension" https://classic.clinicaltrials.gov/ct2/history/NCT05104476?A=12&B=13&C=merged#StudyPageTop
-
Vigtig rente rammer højeste niveau siden 2007: Sådan bliver handelsdagen
Presset stiger på rentemarkedet, og aktiekurserne er under pres. I en morgenmelding fra Nordea, lyder det:“Mandag fortsatte det ubarmhjertige opadgående pres på rentemarkedet, da investorerne vurdered
borsen.dk (borsen.dk)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind